Table 1 Relationship between HSP90 and clinicopathological parameters in HPV16+ cervical cancer patients
From: Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway
Characteristics | Numbers | HSP90 | p value | |
|---|---|---|---|---|
Low | High | |||
Total cases | 38 | 19 | 19 | Â |
Age | Â | Â | Â | Â |
 ≤ 55 | 18 | 10 | 8 | 0.7459 |
 > 55 | 20 | 9 | 11 |  |
Tumor size (cm) | Â | Â | Â | Â |
 ≤ 4.0 | 10 | 8 | 2 | 0.0232 |
 > 4.0 | 28 | 9 | 19 |  |
Histology | Â | Â | Â | Â |
 Squamous | 21 | 9 | 12 | 0.5148 |
 Adenocarcinoma | 17 | 10 | 7 |  |
FIGO stage | Â | Â | Â | Â |
 Ib–IIa | 12 | 8 | 4 | 0.0326 |
 IIb–IIIa | 26 | 7 | 19 |  |
Lymph node metastasis | Â | Â | Â | Â |
 Yes | 27 | 7 | 20 | 0.0117 |
 No | 11 | 8 | 3 |  |